Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Joshua Bomsztyk, Jahanzaib Khwaja & Ashutosh D Wechalekar. (2022) Recent guidelines for high-dose chemotherapy and autologous stem cell transplant for systemic AL amyloidosis: a practitioner’s perspective. Expert Review of Hematology 15:9, pages 781-788.
Read now
Read now
Aida Vahdat shariat panahi, Per Hultman, Karin Öllinger, Gunilla T. Westermark & Katarzyna Lundmark. (2019) Lipid membranes accelerate amyloid formation in the mouse model of AA amyloidosis. Amyloid 26:1, pages 34-44.
Read now
Read now
Per Westermark, Gunilla T. Westermark, Ole B. Suhr & Svante Berg. (2014) Transthyretin-derived amyloidosis: Probably a common cause of lumbar spinal stenosis. Upsala Journal of Medical Sciences 119:3, pages 223-228.
Read now
Read now
Stephen J. Kennel, Sally Macy, Craig Wooliver, Ying Huang, Tina Richey, Eric Heidel & Jonathan S. Wall. (2014) Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice. Amyloid 21:1, pages 45-53.
Read now
Read now
Articles from other publishers (18)
Alice Nevone, Giampaolo Merlini & Mario Nuvolone. (2020) Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses. Frontiers in Pharmacology 11.
Crossref
Crossref
Alan Chait, Laura J. den Hartigh, Shari Wang, Leela Goodspeed, Ilona Babenko, William A. Altemeier & Tomas Vaisar. (2020) Presence of serum amyloid A3 in mouse plasma is dependent on the nature and extent of the inflammatory stimulus. Scientific Reports 10:1.
Crossref
Crossref
Tina Richey, James S. Foster, Angela D. Williams, Anna B. Williams, Alexa Stroh, Sallie Macy, Craig Wooliver, R. Eric Heidel, Siva K. Varanasi, Elizabeth N. Ergen, Dianne J. Trent, Stephen A. Kania, Stephen J. Kennel, Emily B. Martin & Jonathan S. Wall. (2019) Macrophage-Mediated Phagocytosis and Dissolution of Amyloid-Like Fibrils in Mice, Monitored by Optical Imaging. The American Journal of Pathology 189:5, pages 989-998.
Crossref
Crossref
Giampaolo Merlini, Angela Dispenzieri, Vaishali Sanchorawala, Stefan O. Schönland, Giovanni Palladini, Philip N. Hawkins & Morie A. Gertz. (2018) Systemic immunoglobulin light chain amyloidosis. Nature Reviews Disease Primers 4:1.
Crossref
Crossref
Désirée S. Jansson, Caroline Bröjer, Aleksija Neimanis, Torsten Mörner, Charles L. Murphy, Faruk Otman & Per Westermark. (2018) Post mortem findings and their relation to AA amyloidosis in free-ranging Herring gulls (Larus argentatus). PLOS ONE 13:3, pages e0193265.
Crossref
Crossref
Xin Ding, Yingye Liu, Mu Yang, Lin Li, Hiroki Miyahara, Jian Dai, Zhe Xu, Kiyoshi Matsumoto, Masayuki Mori, Keiichi Higuchi & Jinko Sawashita. (2018) Amyloidosis-inducing activity of blood cells in mouse AApoAII amyloidosis. Experimental Animals 67:2, pages 105-115.
Crossref
Crossref
James S. Foster, Angela D. Williams, Sallie Macy, Tina Richey, Alan Stuckey, Daniel Craig Wooliver, Richa Koul-Tiwari, Emily B. Martin, Stephen J. Kennel & Jonathan S. Wall. (2017) A Peptide-Fc Opsonin with Pan-Amyloid Reactivity. Frontiers in Immunology 8.
Crossref
Crossref
P. M. Gaffney. (2016) Amyloid A Amyloidosis. Veterinary Pathology 54:1, pages 5-8.
Crossref
Crossref
K. Watanabe, K. Uchida, J. K. Chambers, N. Ushio & H. Nakayama. (2016) Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice. Veterinary Pathology 54:1, pages 99-110.
Crossref
Crossref
Naeem Muhammad, Tomoaki Murakami, Yasuo Inoshima & Naotaka Ishiguro. (2016) Longitudinal study of experimental induction of AA amyloidosis in mice seeded with homologous and heterologous AA fibrils. Inflammation Research 65:9, pages 689-699.
Crossref
Crossref
M. Ankarcrona, B. Winblad, C. Monteiro, C. Fearns, E. T. Powers, J. Johansson, G. T. Westermark, J. Presto, B.-G. Ericzon & J. W. Kelly. (2016) Current and future treatment of amyloid diseases. Journal of Internal Medicine 280:2, pages 177-202.
Crossref
Crossref
Tomoaki Murakami, Yasuo Inoshima & Naotaka Ishiguro. (2015) Systemic AA amyloidosis as a prion-like disorder. Virus Research 207, pages 76-81.
Crossref
Crossref
N Muhammad, T Murakami, Y Inoshima & N Ishiguro. (2015) Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice. Clinical and Experimental Immunology 181:1, pages 133-141.
Crossref
Crossref
Gunilla T. WestermarkMarcus FändrichPer Westermark. (2015) AA Amyloidosis: Pathogenesis and Targeted Therapy. Annual Review of Pathology: Mechanisms of Disease 10:1, pages 321-344.
Crossref
Crossref
Kanata IBI, Tomoaki MURAKAMI, Wael Mohamed GODA, Naoki KOBAYASHI, Naotaka ISHIGURO & Tokuma YANAI. (2015) Prevalence of amyloid deposition in mature healthy chickens in the flock that previously had outbreaks of vaccine-associated amyloidosis. Journal of Veterinary Medical Science 77:10, pages 1241-1245.
Crossref
Crossref
Katarzyna Lundmark, Aida Vahdat Shariatpanahi & Gunilla T. Westermark. (2013) Depletion of Spleen Macrophages Delays AA Amyloid Development: A Study Performed in the Rapid Mouse Model of AA Amyloidosis. PLoS ONE 8:11, pages e79104.
Crossref
Crossref
Yohei Misumi, Yukio Ando, Nádia P Gonçalves & Maria J Saraiva. (2013) Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis. Laboratory Investigation 93:8, pages 911-920.
Crossref
Crossref
Jana Sponarova, Mario Nuvolone, Charlotte Whicher, Nathalie Frei, Veronika Kana, Petra Schwarz, Gunilla T. Westermark & Adriano Aguzzi. (2013) Efficient Amyloid A Clearance in the Absence of Immunoglobulins and Complement Factors. The American Journal of Pathology 182:4, pages 1297-1307.
Crossref
Crossref